- Prescribing Advice for GPs - https://www.prescriber.org.uk -

NICE Guidance - June 2024

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of June 2024. This month there is one technology appraisal that impacts upon primary care.

The Voxelotor for treating haemolytic anaemia caused by sickle cell disease technology appraisal has been published. This treatment is recommended as an option for treating haemolytic anaemia caused by sickle cell disease in people 12 years and over under certain conditions. This recommendation is contingent on a commercial agreement and as such it is expected prescribing would remain with a specialist.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.